RURO’s Limfinity® Continues Growth Trend

FOR IMMEDIATE RELEASE:
Contact: Timery DeBoer
RURO, Inc.
888-881-7876
sales@ruro.com
www.ruro.com

FREDERICK, MD. (PRWEB) July 24, 2018
 
FOR IMMEDIATE RELEASE:

RURO, Inc., the creator of the Limfinity® laboratory software framework, reported triple digit revenue growth in 2018. Limfinity® Version 7 was released earlier this year, and the RURO development team has continued to expand the Limfinity® portfolio of solutions, including the quickly growing LimitLIS® Laboratory Information System, Study Manager™, and the upcoming Limfinity ML™

Limfinity® has grown more than 110% year over year and additional solid results are expected. Limfinity® Version 7 contained a key set of updates enhancing the user and admin experience for RURO’s customer base. This new version contained a revamped user interface, improvements to UI grids, and a host of other innovations to make Limfinity® run faster and more smoothly than ever before.

Key to Limfinity® growth were new contracts with the US Army, a major national medical system, a top Swiss pharma company, and multiple leading cancer centers. RURO’s LimitLIS® added many new live customer sites, averaging 2.5 per month. The LimitLIS® Toxicology Edition, with its modern user experience and rapid implementation, was the most deployed version of Limfinity®.

“Limfinity customers are popping up everywhere,” says Tom Dolan, RURO’s Chief Executive Officer. “Most importantly, their labs are popping with modernity, efficiency, lowered infrastructure costs, and a new way to work. There is more to come as the Limfinity portfolio of solutions expands into Machine Learning and innovative new information systems for the medical practitioner.”


About RURO, Inc.
Founded in 2006, RURO specializes in Laboratory Information Management and RFID Solutions. Limfinity® is the laboratory software platform used in many of the world’s leading research programs, clinical operations and biobanks. RURO is third party ISO 9001 certified.

Visit RURO at ruro.com for more information.

###
 

View on PRWEB